Search results for " brain"

showing 10 items of 985 documents

Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients

2018

Natriuretic peptides (NP) are involved in the regulation of blood pressure and blood volume, and are elevated in patients with coronary artery disease (CAD). They are used as markers for illness severity, but their role in mental health is not well understood. Recently, A-type NP (ANP) has been associated with reduced anxiety in studies on cardiac patients; however, this study is the first to assess this effect for B-type NP (BNP) and for further dimensions of well-being and mental health. Depression, anxiety, and distress are more common in CAD patients than in the general population and are most likely not only influenced by psychological adaptation but also by neurobiological processes. …

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismCoronary Artery DiseaseAnxiety030204 cardiovascular system & hematologyHospital Anxiety and Depression ScaleSeverity of Illness IndexCoronary artery disease03 medical and health sciences0302 clinical medicineEndocrinologyRisk FactorsInternal medicineNatriuretic Peptide BrainSeverity of illnessHumansMedicinecardiovascular diseasesBiological PsychiatryAgedDepressive DisorderDepressionEndocrine and Autonomic Systemsbusiness.industryType D personalityMiddle Agedmedicine.diseaseMental healthPeptide Fragments3. Good healthPsychotherapyPsychiatry and Mental healthDistressMental HealthQuality of LifeAnxietyFemalemedicine.symptombusinessPsychosocialBiomarkers030217 neurology & neurosurgeryPsychoneuroendocrinology
researchProduct

Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart fai…

2006

BACKGROUND: Decreased exercise capacity is the main factor restricting the daily life of patients with chronic heart failure. N-terminal pro-brain natriuretic peptide (NT pro-BNP) is strongly related to the severity of and is an independent predictor of outcome in chronic heart failure. DESIGN: The study aimed to evaluate the effect of exercise training on functional capacity and on changes in NT pro-BNP levels and to assess the effect of exercise training on quality of life. MATERIALS AND METHODS: Sixty patients (45 men/15 women, mean age 52.7 years; +/-5.3 SD), with stable heart failure (45 ischaemic/hypertensive and 15 idiopathic patients), in New York Heart Association (NYHA) functional…

Malemedicine.medical_specialtyEpidemiologymedicine.drug_classInternal medicineNatriuretic Peptide BrainNatriuretic peptideMedicineHumansIn patientExercise physiologycongestive heart failure exercise capacity gas exchange N-terminal pro-brain natriuretic peptide physical trainingExerciseHeart FailureEjection fractionbusiness.industryPulmonary Gas ExchangeExercise capacityMiddle AgedBrain natriuretic peptidemedicine.diseasePeptide FragmentsPhysical FitnessHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessN-terminal pro-Brain Natriuretic PeptideEuropean journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on EpidemiologyPrevention and Cardiac Rehabilitation and Exercise Physiology
researchProduct

Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.

2018

Background Heart failure (HF) is associated with a high rate of readmissions within 30 days post-discharge and in the following year, especially in frail elderly patients. Biomarker data are scarce in this high-risk population. This study assessed the value of early post-discharge circulating levels of ST2, NT-proBNP, CA125, and hs-TnI for predicting 30-day and 1-year outcomes in comorbid frail elderly patients with HF with mainly preserved ejection fraction (HFpEF). Methods Blood samples were obtained at the first visit shortly after discharge (4.9 ± 2 days). The primary endpoint was the composite of all-cause mortality or HF-related rehospitalization at 30 days and at 1 year. All-cause mo…

Malemedicine.medical_specialtyFrail ElderlyPopulationComorbidity030204 cardiovascular system & hematologylcsh:GeriatricsPatient Readmission03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineCause of DeathNatriuretic Peptide BrainClinical endpointmedicineHumans030212 general & internal medicineProspective StudieseducationProspective cohort studyAgedAged 80 and overHeart Failureeducation.field_of_studyPredictive markerSurrogate endpointbusiness.industryHazard ratioMembrane Proteinsmedicine.diseasePrognosisComorbidityPeptide Fragmentslcsh:RC952-954.6CA-125 AntigenBiomarker (medicine)FemaleGeriatrics and GerontologybusinessBiomarkersResearch ArticleFollow-Up Studies
researchProduct

Gentamicin increases nitric oxide production and induces hearing loss in guinea pigs.

2008

Objectives/Hypothesis: Gentamicin application is an important therapeutic option for Meniere's disease. However, even if given at intervals, a destruction of the cochlea was often observed in various animal models together with an increased content of nitric oxide (NO) and reactive oxygen species. The present study was undertaken to identify the correlation between hearing threshold alteration and the NO production in the lateral wall and organ of Corti of the guinea pig in response to gentamicin application. Study Design: Prospective animal study in guinea pigs. Methods: A single dose of gentamicin (10 mg/kg body weight) was injected intratympanally into male guinea pigs and the auditory b…

Malemedicine.medical_specialtyHearing lossGuinea PigsNitric OxideGuinea pigInternal medicineotorhinolaryngologic diseasesEvoked Potentials Auditory Brain StemMedicineAnimalsProspective StudiesHearing LossOrgan of CortiCochleaAntibacterial agentAbsolute threshold of hearingbusiness.industryAminoglycosideSurgeryCochleamedicine.anatomical_structureEndocrinologyOtorhinolaryngologyOrgan of CortiGentamicinmedicine.symptomGentamicinsbusinessmedicine.drugThe Laryngoscope
researchProduct

Auditory Neuropathy in Children

2001

Auditory neuropathy is a sensorineural disorder characterized by absent or abnormal auditory brainstem evoked potentials and normal cochlear outer hair cell function. A variety of processes is thought to be involved in its pathophysiology and their influence on hearing may be different. We present here the diagnostic sequence and management of two new cases of auditory neuropathy in breastfeeding children.

Malemedicine.medical_specialtyHearing lossHearing Loss SensorineuralOtoacoustic Emissions SpontaneousAuditory neuropathyAudiologyEvoked Potentials Auditory Brain StemVestibulocochlear Nerve Diseasesotorhinolaryngologic diseasesmedicineHumansCochlear Nervebusiness.industryAuditory Perceptual DisordersFollow up studiesInfantGeneral Medicinemedicine.diseasePathophysiologyHair Cells Auditory Outermedicine.anatomical_structureAcoustic StimulationOtorhinolaryngologyFemaleBrainstemHair cellmedicine.symptombusinessBrain StemFollow-Up StudiesActa Oto-Laryngologica
researchProduct

An experimental comparative study of dexamethasone, melatonin and tacrolimus in noise-induced hearing loss.

2008

The calcineurin inhibitor tacrolimus (TCR) and the pineal gland hormone and antioxidant melatonin (MLT) have been shown to possess otoprotective properties against noise-induced hearing loss (NIHL). In contrast, dexamethasone (DXM) was not effective as an otoprotective agent against NIHL. Further studies are needed to understand the exact molecular mechanisms involved.Exposure to noise pollution and use of audio devices for long periods of time at high volume is known to cause hearing loss or NIHL. Our goal was to evaluate the effectiveness of various known compounds such as the anti-inflammatory DXM, the antioxidant MLT and the immunosuppressant TCR against NIHL.Thirty-two Wistar rats were…

Malemedicine.medical_specialtyHearing lossOtoacoustic Emissions SpontaneousAnti-Inflammatory AgentsAntioxidantsDexamethasoneTacrolimusMelatoninPineal glandInternal medicineotorhinolaryngologic diseasesmedicineEvoked Potentials Auditory Brain StemAnimalsRats WistarDexamethasoneMelatoninbusiness.industryReverse Transcriptase Polymerase Chain ReactionTumor Necrosis Factor-alphaGeneral Medicinemedicine.diseaseTacrolimusRatsCalcineurinHair Cells Auditory OuterEndocrinologymedicine.anatomical_structureOtorhinolaryngologyHearing Loss Noise-Inducedmedicine.symptombusinessProto-Oncogene Proteins c-fosNoise-induced hearing lossImmunosuppressive AgentsHormonemedicine.drugActa oto-laryngologica
researchProduct

Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression.

2018

Patients with coronary heart disease (CHD) suffer from physical limitations, but also from psychological distress. Natriuretic peptides may be involved in the neurobiological processes that modulate psychological adaptation, as they are increased in heart disease and seem to have an anxiolytic-like function. Longitudinal data on this association are scarce.To assess the relationship between NT-proBNP and anxiety (Hospital Anxiety and Depression Scale (HADS)), we used secondary data from a multicenter trial from baseline to 24 months. Patients (N = 308, 80.8% male, mean age 60.1 years) had stable CHD and moderate levels of depression (HADS ≥8).Multiple linear regression adjusted for age, sex…

Malemedicine.medical_specialtyHeart diseasemedicine.drug_classDiseaseCoronary Artery DiseaseAnxietyHospital Anxiety and Depression ScaleCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineMulticenter trialNatriuretic Peptide BrainNatriuretic peptideMedicineHumanscardiovascular diseases030212 general & internal medicineLongitudinal StudiesDepression (differential diagnoses)Depressive Disorderbusiness.industryAnxiety ; Coronary Heart Disease ; Depression ; Natriuretic PeptideMiddle Agedmedicine.diseasePeptide FragmentsPsychotherapyPsychiatry and Mental healthClinical PsychologyAnxietyFemalemedicine.symptombusinesshormones hormone substitutes and hormone antagonists030217 neurology & neurosurgeryJournal of psychosomatic research
researchProduct

Inflammatory pathways in patients with heart failure and preserved ejection fraction.

2008

Immune activation is well established in patients with chronic heart failure and reduced ejection fraction (HF and reduced EF) and is associated with an impaired prognosis. Patients with heart failure and preserved ejection fraction (HF and preserved EF) have an impaired prognosis as well. It is not known whether they have signs of immune activation.We studied patients with HF and preserved EF (n=17, NYHA II [n=7]/III [n=10]) and patients with HF and reduced EF (n=17 NYHA II [n=1]/III [n=16]) and 20 controls. Echocardiography demonstrated preserved ejection fraction (LVEF 59+/-9%), but LV hypertrophy in patients with preserved EF as compared with patients with reduced EF (LVEF 23+/-5%). We …

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentHemodynamicsInflammationVentricular Function LeftInternal medicineNatriuretic Peptide BrainmedicineHumansIn patientReceptorAgedAged 80 and overHeart FailureInflammationEjection fractionbusiness.industryStroke VolumeMiddle Agedmedicine.diseasePeptide FragmentsCytokineHeart failureCardiologyCytokinesFemalemedicine.symptomInflammation MediatorsCardiology and Cardiovascular MedicinebusinessSignal TransductionInternational journal of cardiology
researchProduct

Hypertonic saline solution and decompressive craniectomy for treatment of intracranial hypertension in pediatric severe traumatic brain injury.

2002

Experimental data 8 –11 and first clinical results in adults 12,13 suggest that hypertonic saline ( 1.0) may be highly effective in lowering ICP even when mannitol has lost its therapeutic potential after prolonged and repeated use. In children, only limited experience exists with the use of hypertonic saline solutions: a randomized prospective study in children with severe head injury compared the effects on ICP (increased to 15–20 mm Hg) of isotonic (0.9% NaCl) and hypertonic (3% NaCl) saline injections, demonstrating a beneficial effect of the hypertonic solution. 14 Another prospective randomized trial compared the effects of continuous infusion of either lactated Ringer’s solution (277…

Malemedicine.medical_specialtyIntracranial PressureTraumatic brain injurymedicine.medical_treatmentBrain damageCritical Care and Intensive Care MedicineDrug Administration ScheduleInjury Severity ScorePreoperative CaremedicineHumansChildInfusions IntravenousSalineOsmolePostoperative CareSaline Solution Hypertonicbusiness.industryHead injurySodiumGlasgow Coma ScaleAccidents Trafficmedicine.diseaseDecompression SurgicalHypertonic salineSurgeryAnesthesiaBrain InjuriesSurgeryDecompressive craniectomyAccidental Fallsmedicine.symptomIntracranial HypertensionbusinessTomography X-Ray ComputedCraniotomyThe Journal of trauma
researchProduct

Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice

2015

Doxorubicin (DOX) is known to induce serious cardiotoxicity, which is believed to be mediated by oxidative stress and complex interactions with iron. However, the relationship between iron and DOX-induced cardiotoxicity remains controversial and the role of iron chelation therapy to prevent cardiotoxicity is called into question. Firstly, we evaluated in vitro the effects of DOX in combination with dextran-iron on cell viability in cultured H9c2 cardiomyocytes and EMT-6 cancer cells. Secondly, we used an in vivo murine model of iron overloading (IO) in which male C57BL/6 mice received a daily intra-peritoneal injection of dextran-iron (15mg/kg) for 3weeks (D0-D20) and then (D21) a single su…

Malemedicine.medical_specialtyIron OverloadCell SurvivalHeart VentriclesIronCardiomegaly030204 cardiovascular system & hematologyToxicologymedicine.disease_causeCell LineVentricular MyosinsMice03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemAtrial natriuretic peptideIn vivoCell Line TumorInternal medicineNatriuretic Peptide Brainpolycyclic compoundsmedicineAnimalsMyocytes CardiacDoxorubicinViability assay030304 developmental biologyPharmacology0303 health sciencesCardiotoxicityCell growthChemistryDextransBrain natriuretic peptideCardiotoxicity[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemUp-Regulation3. Good healthMice Inbred C57BLOxidative Stresscell proliferationEndocrinologyDoxorubicincardiovascular systemOxidative stressmedicine.drugToxicology and Applied Pharmacology
researchProduct